Nova Minerals NVA
Three insiders bought $47K over 11 days, within the 30-day window
Last open-market buy
- Christopher Gerteisen $22K
- Joshua I. Girnun $20K
- Avi Geller $5K
Form 4
Insider buys and sales, small caps first
Source: Form 4 filings on SEC EDGAR
Type a ticker for one company's Form 4s, or read today's open-market trades at companies with a public float under $300M (All companies is one tap away): buys first, then sales, cluster buys and each insider's record across companies.
Open-market buys, last day8
Cluster buys, last 30 days, under $300M float1
Open-market sales, last day9
Planned sales (10b5-1), last day3
Insiders you follow
Cluster buys, last 30 days, under $300M float
Companies whose last cluster buy was in the last 30 days.
Trades filed since Nov 3
Notes on each row are as each Form 4 states them, next to SEC Tracker's own records of the company's filings and other insiders' buys. The Stake column is the change in their holding.
| Traded | Company | Insider | Trade | Value | Stake | Notes |
|---|---|---|---|---|---|---|
| Nov 2, 2026 Filed Nov 3, 2026 | Starz Entertainment STRZ | Jeffrey Hirsch CEO | Open-market buy 5,000 shares | $111K at $22.13 | +8% | Their first open-market buy here in SEC Tracker's records. 4 days after the company's 8-K filed Oct 29, 2026. |
| Nov 2, 2026 Filed Nov 3, 2026 | ProMIS Neurosciences PMN | Neil Cashman Chief Scientific Officer | Open-market buy 10,000 shares | $39K at $3.86 | +221% | Their first open-market buy here in SEC Tracker's records. 80 days after the company's SCHEDULE 13G/A filed Aug 14, 2026. |
| Nov 3, 2026 | Community Bancorp CMTV | Christopher L. Caldwell Officer | Open-market buy 500 shares | $21K at $42.98 | +4% | Their first open-market buy here in SEC Tracker's records. 7 days after the company's 8-K filed Oct 27, 2026. |
| Nov 2, 2026 Filed Nov 3, 2026 | Starz Entertainment STRZ | James M. Kapenstein Officer | Open-market buy 460 shares | $11K at $22.84 | +4% | Their first open-market buy here in SEC Tracker's records. 4 days after the company's 8-K filed Oct 29, 2026. |
| Oct 30, 2026 Filed Nov 3, 2026 | ProMIS Neurosciences PMN | Eugene Williams Director | Open-market buy 1,316 shares | $5K at $3.99 | +11% | Their first open-market buy here in SEC Tracker's records. 77 days after the company's SCHEDULE 13G/A filed Aug 14, 2026. |
| Nov 2, 2026 | Dolphin Entertainment DLPN | William O'Dowd IV CEO | Open-market buy 5,000 shares | $5K at $0.99 | +1% | 38 days after the company's DEFA14A filed Sep 25, 2026. |
| Nov 2, 2026 Filed Nov 3, 2026 | Replimune Group REPL | Kapil Dhingra Director | Open-market sale 21,500 shares | $409K at $19.00 | −50% | The filing does not mark this sale as under a Rule 10b5-1 plan. The same day as a Form 144 notice of a planned insider sale filed Nov 2, 2026. |
| Nov 2, 2026 Filed Nov 3, 2026 | NorthEast Community Bancorp NECB | John F McKenzie Director | Open-market sale 9,700 shares | $284K at $29.29 | −100% | The filing does not mark this sale as under a Rule 10b5-1 plan. The same day as a Form 144 notice of a planned insider sale filed Nov 2, 2026. |
| Nov 2, 2026 Filed Nov 3, 2026 | Artiva Biotherapeutics ARTV | Fred Aslan CEO | Open-market sale 62,178 shares | $260K at $4.18 | −4% | The filing does not mark this sale as under a Rule 10b5-1 plan. 6 days after the company's 8-K filed Oct 27, 2026. |
| Nov 2, 2026 Filed Nov 3, 2026 | Artiva Biotherapeutics ARTV | Christopher Horan Officer | Open-market sale 10,423 shares | $44K at $4.18 | −3% | The filing does not mark this sale as under a Rule 10b5-1 plan. 6 days after the company's 8-K filed Oct 27, 2026. |
| Nov 2, 2026 Filed Nov 3, 2026 | EGAIN EGAN | Rao Jadcherla Chandrasekhar Officer | Planned sale (10b5-1) 6,000 shares | $35K at $5.90 | −82% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Nov 2, 2026. |
| Nov 2, 2026 Filed Nov 3, 2026 | Artiva Biotherapeutics ARTV | Jennifer Bush Officer | Open-market sale 8,439 shares | $35K at $4.18 | −2% | The filing does not mark this sale as under a Rule 10b5-1 plan. 6 days after the company's 8-K filed Oct 27, 2026. |
| Nov 2, 2026 Filed Nov 3, 2026 | Artiva Biotherapeutics ARTV | Subhashis Banerjee Chief Medical Officer | Open-market sale 1,110 shares | $5K at $4.18 | −1% | The filing does not mark this sale as under a Rule 10b5-1 plan. 6 days after the company's 8-K filed Oct 27, 2026. |
| Nov 2, 2026 Filed Nov 3, 2026 | Atomera ATOM | Robert J Mears CTO | Planned sale (10b5-1) 1,000 shares | $3K at $3.40 | −<1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Nov 2, 2026. |
| Nov 2, 2026 Filed Nov 3, 2026 | Heritage Global HGBL | James Edward Sklar Officer | Planned sale (10b5-1) 2,500 shares | $3K at $1.23 | −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Nov 2, 2026. |
| Nov 2, 2026 Filed Nov 3, 2026 | Fold Holdings FLD | William Brian Poppic Reeves CEO | Open-market sale 4,572 shares | $3K at $0.55 | −<1% | The filing does not mark this sale as under a Rule 10b5-1 plan. The same day as a Form 144 notice of a planned insider sale filed Nov 2, 2026. |
4 trades under $1K are left out here and listed under Everything.
Insider records
The 10 insiders in these trades with the most bought and sold on the open market across every company, in SEC Tracker's records.
| Insider | Buys | Sales | Bought | Sold | Companies |
|---|---|---|---|---|---|
| Robert J Mears | 0 | 142 | $4.1M | 1 | |
| Fred Aslan | 0 | 2 | $413K | 1 | |
| Kapil Dhingra | 0 | 1 | $409K | 1 | |
| John F McKenzie | 0 | 1 | $284K | 1 | |
| Jeffrey Hirsch | 1 | 0 | $111K | 1 | |
| Christopher Horan | 0 | 1 | $44K | 1 | |
| William O'Dowd IV | 8 | 0 | $39K | 1 | |
| Neil Cashman | 1 | 0 | $39K | 1 | |
| Rao Jadcherla Chandrasekhar | 0 | 1 | $35K | 1 | |
| Jennifer Bush | 0 | 1 | $35K | 1 |
Open-market trades are Form 4 transaction codes P (purchase) and S (sale). Planned sales are those the filing marks as made under a Rule 10b5-1 plan. A P-code buy at the offering price within a day of the company's FWP, 424B prospectus or offering 8-K is marked Bought in the offering and left out of open-market buy counts and cluster buys. Prices and values are as stated in each Form 4. Stock prices aren't shown on this page. Not investment advice.